Magnesium deficiency explained

Magnesium deficiency
Synonyms:Hypomagnesia, hypomagnesemia
Field:Endocrinology
Symptoms:Tremor, poor coordination, nystagmus, seizures
Complications:Seizures, cardiac arrest (torsade de pointes), low potassium
Causes:Alcoholism, starvation, diarrhea, increased urinary loss, poor absorption from the intestines, certain medications
Diagnosis:Blood levels < 0.6 mmol/L (1.46 mg/dL)
Treatment:Magnesium salts
Frequency:Relatively common (hospitalized people)

Magnesium deficiency is an electrolyte disturbance in which there is a low level of magnesium in the body.[1] Symptoms include tremor, poor coordination, muscle spasms, loss of appetite, personality changes, and nystagmus. Complications may include seizures or cardiac arrest such as from torsade de pointes. Those with low magnesium often have low potassium.

Causes include low dietary intake, alcoholism, diarrhea, increased urinary loss, and poor absorption from the intestines.[2] [3] [4] Some medications may also cause low magnesium, including proton pump inhibitors (PPIs) and furosemide. The diagnosis is typically based on finding low blood magnesium levels, also called hypomagnesemia.[5] Normal magnesium levels are between 0.6 and 1.1 mmol/L (1.46–2.68 mg/dL) with levels less than 0.6 mmol/L (1.46 mg/dL) defining hypomagnesemia.[2] Specific electrocardiogram (ECG) changes may be seen.[2]

Treatment is with magnesium either by mouth or intravenously. For those with severe symptoms, intravenous magnesium sulfate may be used.[2] Associated low potassium or low calcium should also be treated. The condition is relatively common among people in hospitals.[6]

Signs and symptoms

Deficiency of magnesium can cause tiredness, generalized weakness, muscle cramps, abnormal heart rhythms, increased irritability of the nervous system with tremors, paresthesias, palpitations, low potassium levels in the blood, hypoparathyroidism which might result in low calcium levels in the blood, chondrocalcinosis, spasticity and tetany, migraines, epileptic seizures,[7] basal ganglia calcifications[8] and in extreme and prolonged cases coma, intellectual disability or death.[9] Magnesium deficiency is strongly associated with and appears to contribute to obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, although the causal mechanism is not fully understood.[10]

Causes

Magnesium deficiency may result from gastrointestinal or kidney causes. Gastrointestinal causes include low dietary intake of magnesium, reduced gastrointestinal absorption or increased gastrointestinal loss due to rapid gastrointestinal transits. Kidney causes involve increased excretion of magnesium. Poor dietary intake of magnesium has become an increasingly important factor: many people consume diets high in refined foods such as white bread and polished rice which have been stripped of magnesium-rich plant fiber.[11]

Magnesium deficiency is common in hospitalized patients. Up to 12% of all people admitted to hospital, and as high as 60–65% of people in an intensive care unit (ICU), have hypomagnesemia.[12]

About 57% of the US population does not meet the US RDA for dietary intake of magnesium.[13] Kidneys are very efficient at maintaining body levels; however, if the diet is deficient, or certain medications such as diuretics or proton pump inhibitors are used,[14] or in chronic alcoholism, levels may drop.

Deficiencies may be due to the following conditions:

Medications

Genetics

Metabolic abnormalities

Other

Pathophysiology

Magnesium is ubiquitous in the human body as well as being present in all living organisms and the ion is a known co-factor in over known 300 enzymatic reactions including DNA and RNA replication, protein synthesis, acting as an essential co-factor of ATP during its phosphorylation via ATPase. It is also extensively involved in intracellular signaling.[28] It is involved in protein synthesis, regulating glucose, lipid and protein metabolism, muscle and nerve functioning, vascular tone (affecting blood vessel contraction, thus helping to regulate blood pressure), bone development, energy production, the maintenance of normal heart rhythm, and the regulation of glucose, among other important roles.[29] Physiologically, it acts as a calcium antagonist. Thus, the effects of low magnesium are widespread. Low magnesium intake over time can increase the risk of illnesses, including high blood pressure and heart disease, diabetes mellitus type 2, osteoporosis, and migraines.[29]

Magnesium has several effects:

Potassium

Low potassium levels are usually associated with hypomagnesemia. Low magnesium levels act to inhibit the sodium-potassium pump (Na-K-ATPase) which normally pumps sodium to the extracellular space and potassium into the intracellular space, using ATP as energy to pump both cations against their concentration gradient, to maintain relatively high levels of potassium in the intracellular compartment and high levels of sodium in the extracellular space. Hypomagnesemia also causes activation of the Renal outer medullary potassium channel (ROMK), a potassium channel which causes potassium losses in the urine via the cortical collecting duct in the kidney. And hypomagnesemia prevents low potassium levels from activating the sodium-chloride cotransporter (NCC) and downregulates NCC levels, which prevents sodium and chloride reabsorption from the kidney tubule. The inhibition of the sodium-potassium pump results in more potassium remaining in the extracellular space (interstitial fluid and plasma). And this potassium is then lost as blood is filtered in the kidney as ROMK channel activation causes potassium losses in the cortical collecting duct and NCC inhibition causes decreased sodium-chloride reabsorption by kidney tubules, with subsequent increased sodium-chloride (and water) delivery to the distal tubule, and associated diuresis and kaliuresis (kidney potassium loss in the urine). Overall, the net effect of low magnesium levels in the body is renal potassium losses (in the urine), thus clinically, low potassium levels are often refractory to supplementation without also correcting low magnesium levels.[30]

Patients with diabetic ketoacidosis should have their magnesium levels monitored to ensure that the serum loss of potassium, which is driven intracellularly by insulin administration, is not exacerbated by additional urinary losses.

Calcium

Release of calcium from the sarcoplasmic reticulum is inhibited by magnesium. Thus hypomagnesemia results in an increased intracellular calcium level. This inhibits the release of parathyroid hormone, which can result in hypoparathyroidism and hypocalcemia. Furthermore, it makes skeletal and muscle receptors less sensitive to parathyroid hormone.[12]

Arrhythmia

Magnesium is needed for the adequate function of the Na+/K+-ATPase pumps in cardiac myocytes, the muscles cells of the heart. A lack of magnesium inhibits reuptake of potassium, causing a decrease in intracellular potassium. This decrease in intracellular potassium results in tachycardia.

Pre-eclampsia

Magnesium has an indirect antithrombotic effect upon platelets and endothelial function. Magnesium increases prostaglandins, decreases thromboxane, and decreases angiotensin II, microvascular leakage, and vasospasm through its function similar to calcium channel blockers. Convulsions are the result of cerebral vasospasm. The vasodilatatory effect of magnesium seems to be the major mechanism.

Asthma

Magnesium exerts a bronchodilatatory effect, probably by antagonizing calcium-mediated bronchoconstriction.[31]

Neurological effects

Diabetes mellitus

Magnesium deficiency is frequently observed in people with type 2 diabetes mellitus, with an estimated prevalence ranging between 11 and 48%.[32] Magnesium deficiency is strongly associated with high glucose and insulin resistance, which indicate that it is common in poorly controlled diabetes.[33] Patients with type 2 diabetes and a magnesium deficiency have a higher risk of heart failure, atrial fibrillation and microvascular complications.[34] Oral magnesium supplements has been demonstrated to improve insulin sensitivity and lipid profile.[35] [36] [37] A 2016 meta-analysis not restricted to diabetic subjects found that increasing dietary magnesium intake, while associated with a reduced risk of stroke, heart failure, diabetes, and all-cause mortality, was not clearly associated with lower risk of coronary heart disease (CHD) or total cardiovascular disease (CVD).[38]

Homeostasis

Magnesium rich foods include cereals, green vegetables (with magnesium being a main component of chlorophyll), beans, and nuts.[39] It is absorbed primarily in the small intestine via paracellular transport; passing between intestinal cells. Magnesium absorption in the large intestine is mediated by the transporters TRPM6 and TRPM7.

The body contains about 25 grams of magnesium. Of the body's magnesium, 50-60% is stored in bone, with the remainder, about 40-50%, being stored in muscle or soft tissue, with about 1% being in the plasma.[40] Therefore, normal plasma levels of magnesium may sometimes be seen despite a person being in a state of magnesium deficiency and plasma magnesium levels may underestimate the level of deficiency. Plasma magnesium levels may more accurately reflect magnesium stores when consideration is also given to urinary magnesium losses and oral intake of magnesium.

Inside cells, 90-95% of magnesium is bound to ligands, including ATP, ADP, citrate, other proteins and nucleic acids. In the plasma, 30% of magnesium is bound to proteins via free fatty acids, therefore elevated levels of free fatty acids are associated with hypomagnesemia as well as a possible risk of cardiovascular disease.

The kidneys regulate magnesium levels by reabsorbing magnesium from the tubules. In the proximal tubule (at the beginning of the nephron, the functional unit of the kidney) 20% of magnesium is reabsorbed via paracellular transport with claudin 2 and claudin 12 forming channels to allow for reabsorption. 70% of magnesium is reabsorbed in the thick ascending limb of the loop of Henle where claudins 16 and 19 form the channels to allow for reabsorption. In the distal convoluted tubule, 5-10% of magnesium is reabsorbed transcellularly (through the cells) via the transporters TRPM6 and TRPM7. Epidermal growth factor and insulin activate TRPM6 and 7 and increase magnesium levels via increased renal reabsorption.

Diagnosis

Magnesium deficiency or depletion is a low total body level of magnesium; it is not easy to measure directly.

Blood magnesium

Typically the diagnosis is based on finding hypomagnesemia, a low blood magnesium level,[41] which often reflects low body magnesium; however, magnesium deficiency can be present without hypomagnesemia, and vice versa.[42] A plasma magnesium concentration of less than 0.6 mmol/L (1.46 mg/dL) is considered to be hypomagnesemia; severe disease generally has a level of less than 0.5 mmol/L (1.25 mg/dL).

Electrocardiogram

The electrocardiogram (ECG) change may show a tachycardia with a prolonged QT interval.[43] Other changes may include prolonged PR interval, ST segment depression, flipped T waves, and long QRS duration.[2]

Treatments

See main article: Magnesium (medical use).

Treatment of magnesium deficiency depends on the degree of deficiency and the clinical effects. Replacement by mouth is appropriate for people with mild symptoms, while intravenous replacement is recommended for people with severe effects.[44]

Numerous oral magnesium preparations are available. In two trials of magnesium oxide, one of the most common forms in magnesium dietary supplements because of its high magnesium content per weight, was found to be less bioavailable than magnesium citrate, chloride, lactate or aspartate.[45] [46] Amino-acid chelate was also less bioavailable.[47]

Intravenous magnesium sulfate (MgSO4) can be given in response to heart arrhythmias to correct for hypokalemia, preventing pre-eclampsia, and has been suggested as having a potential use in asthma.[2]

Food

Food sources of magnesium include leafy green vegetables, beans, nuts, and seeds.[48]

Epidemiology

Hypomagnesemia may be seen in 3-10% of the general population. It is present in an estimated 10-30% of people with diabetes, 10-60% of hospitalized people and greater than 65% of people in the ICU. In hospitalized patients, hypomagnesemia is associated with an increased length of stay. And in those in an ICU, it is associated with a higher risk of requiring mechanical ventilation, and death.[49] [50] In population based cohort studies, chronic magnesium deficiency was associated with an increased risk of cardiovascular death and overall death.[51]

History

Magnesium deficiency in humans was first described in the medical literature in 1934.[52]

Plants

Magnesium deficiency is a detrimental plant disorder that occurs most often in strongly acidic, light, sandy soils, where magnesium can be easily leached away. Magnesium is an essential macronutrient constituting 0.2-0.4% of plants' dry matter and is necessary for normal plant growth.[53] Excess potassium, generally due to fertilizers, further aggravates the stress from magnesium deficiency,[54] as does aluminium toxicity.[55]

Magnesium has an important role in photosynthesis because it forms the central atom of chlorophyll.[53] Therefore, without sufficient amounts of magnesium, plants begin to degrade the chlorophyll in the old leaves. This causes the main symptom of magnesium deficiency, interveinal chlorosis, or yellowing between leaf veins, which stay green, giving the leaves a marbled appearance. Due to magnesium's mobile nature, the plant will first break down chlorophyll in older leaves and transport the Mg to younger leaves which have greater photosynthetic needs. Therefore, the first sign of magnesium deficiency is the chlorosis of old leaves which progresses to the young leaves as the deficiency progresses.[56] Magnesium also acts as an activator for many critical enzymes, including ribulosebisphosphate carboxylase (RuBisCO) and phosphoenolpyruvate carboxylase (PEPC), both essential enzymes in carbon fixation. Thus low amounts of Mg lead to a decrease in photosynthetic and enzymatic activity within the plants. Magnesium is also crucial in stabilizing ribosome structures, hence, a lack of magnesium causes depolymerization of ribosomes leading to premature aging of the plant.[53] After prolonged magnesium deficiency, necrosis and dropping of older leaves occurs. Plants deficient in magnesium also produce smaller, woodier fruits.

Magnesium deficiency in plants may be confused with zinc or chlorine deficiencies, viruses, or natural aging, since all have similar symptoms. Adding Epsom salts (as a solution of 25 grams per liter or 4 oz per gal) or crushed dolomitic limestone to the soil can rectify magnesium deficiencies. An organic treatment is to apply compost mulch, which can prevent leaching during excessive rainfall and provide plants with sufficient amounts of nutrients, including magnesium.[57]

See also

External links

Notes and References

  1. Web site: Definition of Magnesium Deficiency. MedicineNet.com. 31 May 2014. 31 May 2014. https://web.archive.org/web/20140531090430/http://www.medterms.com/script/main/art.asp?articlekey=4244. dead.
  2. Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, Brugger H, Deakin CD, Dunning J, Georgiou M, Handley AJ, Lockey DJ, Paal P, Sandroni C, Thies KC, Zideman DA, Nolan JP . 6 . European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution . Resuscitation . 81 . 10 . 1400–1433 . October 2010 . 20956045 . 10.1016/j.resuscitation.2010.08.015 .
  3. de Baaij JH, Hoenderop JG, Bindels RJ . Magnesium in man: implications for health and disease . Physiological Reviews . 95 . 1 . 1–46 . January 2015 . 25540137 . 10.1152/physrev.00012.2014 . 10.1.1.668.9777 . 4999601 .
  4. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH . Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? . Diabetes . 65 . 1 . 3–13 . January 2016 . 26696633 . 10.2337/db15-1028 . free .
  5. Book: Goldman L, Schafer AI . Goldman-Cecil Medicine E-Book . 2015 . Elsevier Health Sciences . 9780323322850 . 775 . en.
  6. News: Hypomagnesemia . Merck Manuals Professional Edition . 27 October 2018.
  7. Yuen AW, Sander JW . Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis . Epilepsy Research . 100 . 1–2 . 152–156 . June 2012 . 22406257 . 10.1016/j.eplepsyres.2012.02.004 . 23147775 .
  8. Web site: Basal Ganglia Calcification with Hypomagnesemia. 2021-06-03. www.japi.org. 2022-06-30. https://web.archive.org/web/20220630001649/https://www.japi.org/t284a4c4/basal-ganglia-calcification-with-hypomagnesemia#:~:text=2%20Thus%20magnesium%20deficiency%20causes,nephrocalcinosis%20and%20basal%20ganglia%20calcification.. dead.
  9. Viering DH, de Baaij JH, Walsh SB, Kleta R, Bockenhauer D . Genetic causes of hypomagnesemia, a clinical overview . Pediatric Nephrology . 32 . 7 . 1123–1135 . July 2017 . 27234911 . 5440500 . 10.1007/s00467-016-3416-3 .
  10. Piuri . Gabriele . Zocchi . Monica . Della Porta . Matteo . Ficara . Valentina . Manoni . Michele . Zuccotti . Gian Vincenzo . Pinotti . Luciano . Maier . Jeanette A. . Cazzola . Roberta . February 2021 . Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes . Nutrients . en . 13 . 2 . 320 . 10.3390/nu13020320 . free . 33499378 . 7912442 . 2072-6643.
  11. DiNicolantonio JJ, O'Keefe JH, Wilson W . Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis . Open Heart . 5 . 1 . e000668 . 2018 . 29387426 . 5786912 . 10.1136/openhrt-2017-000668 .
  12. Agus ZS . Hypomagnesemia . Journal of the American Society of Nephrology . 10 . 7 . 1616–1622 . July 1999 . 10405219 . 10.1681/ASN.V1071616 . free .
  13. Web site: Nutrient Intakes Percent of population 2 years old and over with adequate intakes based on average requirement . 2012-02-11 . 2009-07-29 . Community Nutrition Mapping Project.
  14. Web site: FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). fda.gov. F.D.A. U.S. Food and Drug Administration. 8 November 2014.
  15. Whang R, Hampton EM, Whang DD . Magnesium homeostasis and clinical disorders of magnesium deficiency . The Annals of Pharmacotherapy . 28 . 2 . 220–226 . February 1994 . 8173141 . 10.1177/106002809402800213 . 23442909 .
  16. Book: Gragossian A, Bashir K, Friede R . Hypomagnesemia. 2021. http://www.ncbi.nlm.nih.gov/books/NBK500003/ . StatPearls. Treasure Island (FL). StatPearls Publishing. 29763179. 2021-06-03 .
  17. Web site: Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use . www.fda.gov . dead . https://web.archive.org/web/20110304093609/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm . 2011-03-04.
  18. Sheen E, Triadafilopoulos G . Adverse effects of long-term proton pump inhibitor therapy . Digestive Diseases and Sciences . 56 . 4 . 931–950 . April 2011 . 21365243 . 10.1007/s10620-010-1560-3 . 34550326 .
  19. Viering D, Schlingmann KP, Hureaux M, Nijenhuis T, Mallett A, Chan MM, van Beek A, van Eerde AM, Coulibaly JM, Vallet M, Decramer S, Pelletier S, Klaus G, Kömhoff M, Beetz R, Patel C, Shenoy M, Steenbergen EJ, Anderson G, Bongers EM, Bergmann C, Panneman D, Rodenburg RJ, Kleta R, Houillier P, Konrad M, Vargas-Poussou R, Knoers NV, Bockenhauer D, de Baaij JH . 6 . Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA . Journal of the American Society of Nephrology . 33 . 2 . 305–325 . February 2022 . 34607911 . 8819995 . 10.1681/ASN.2021050596 .
  20. Chareonpong-Kawamoto N, Yasumoto K . Selenium deficiency as a cause of overload of iron and unbalanced distribution of other minerals . Bioscience, Biotechnology, and Biochemistry . 59 . 2 . 302–306 . February 1995 . 7766029 . 10.1271/bbb.59.302 .
  21. Johnson . S. . The multifaceted and widespread pathology of magnesium deficiency . Medical Hypotheses . Elsevier BV . 56 . 2 . 2001 . 0306-9877 . 10.1054/mehy.2000.1133 . 163–170. 11425281 .
  22. Al-Ghamdi . Saeed M.G. . Cameron . Eugene C. . Sutton . Roger A.L. . Magnesium Deficiency: Pathophysiologic and Clinical Overview . American Journal of Kidney Diseases . Elsevier BV . 24 . 5 . 1994 . 0272-6386 . 10.1016/s0272-6386(12)80667-6 . 737–752. 7977315 .
  23. Rivlin RS . Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review) . Journal of the American College of Nutrition . 13 . 5 . 416–423 . October 1994 . 7836619 . 10.1080/07315724.1994.10718430 .
  24. Book: Chapter 9. Fluids and Electrolytes . Gomella LG, Haist SA . 2007 . Clinician's Pocket Reference: The Scut Monkey . 11th . McGraw Hill . https://accessmedicine.mhmedical.com/content.aspx?bookid=365&sectionid=43074918 . 978-0-07-145428-5 .
  25. Book: Desai S, Seidler M . 2017 . Metabolic & Endocrine Emergencies . Stone C, Humphries RL . Current Diagnosis & Treatment: Emergency Medicine . 8th . McGraw Hill . https://accessmedicine.mhmedical.com/content.aspx?bookid=2172&sectionid=165068628 . 978-0-07-184061-3 .
  26. Flink EB . Magnesium deficiency in alcoholism . Alcoholism: Clinical and Experimental Research . 10 . 6 . 590–594 . December 1986 . 3544909 . 10.1111/j.1530-0277.1986.tb05150.x .
  27. Sihler KC, Napolitano LM . Complications of massive transfusion . Chest . 137 . 1 . 209–220 . January 2010 . 20051407 . 10.1378/chest.09-0252 .
  28. al-Ghamdi SM, Cameron EC, Sutton RA . Magnesium deficiency: pathophysiologic and clinical overview . American Journal of Kidney Diseases . 24 . 5 . 737–752 . November 1994 . 7977315 . 10.1016/s0272-6386(12)80667-6 .
  29. Web site: Magnesium: Fact Sheet for Health Professionals. nih.gov. National Institutes of Health. 8 November 2014.
  30. Huang CL, Kuo E . Mechanism of hypokalemia in magnesium deficiency . Journal of the American Society of Nephrology . 18 . 10 . 2649–2652 . October 2007 . 17804670 . 10.1681/ASN.2007070792 . free .
  31. Mills R, Leadbeater M, Ravalia A . Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic . Anaesthesia . 52 . 8 . 782–785 . August 1997 . 9291766 . 10.1111/j.1365-2044.1997.176-az0312.x . free .
  32. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT . Hypomagnesemia in patients with type 2 diabetes . Clinical Journal of the American Society of Nephrology . 2 . 2 . 366–373 . March 2007 . 17699436 . 10.2215/CJN.02960906 . free .
  33. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT . Hypomagnesemia in patients with type 2 diabetes . Clinical Journal of the American Society of Nephrology . 2 . 2 . 366–373 . March 2007 . 17699436 . 10.1530/EJE-16-0517 . free .
  34. Oost LJ, van der Heijden AA, Vermeulen EA, Bos C, Elders PJ, Slieker RC, Kurstjens S, van Berkel M, Hoenderop JG, Tack CJ, Beulens JW, de Baaij JH . 6 . Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes . Diabetes Care . 44 . 8 . 1757–1765 . August 2021 . 34385344 . 10.2337/dc21-0236 . 236991270 . free .
  35. Rodríguez-Morán M, Guerrero-Romero F . Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial . Diabetes Care . 26 . 4 . 1147–1152 . April 2003 . 12663588 . 10.2337/diacare.26.4.1147 . free .
  36. Asbaghi O, Moradi S, Nezamoleslami S, Moosavian SP, Hojjati Kermani MA, Lazaridi AV, Miraghajani M . The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials . Biological Trace Element Research . 199 . 3 . 861–873 . March 2021 . 32468224 . 10.1007/s12011-020-02209-5 . 2021BTER..199..861A . 218978772 .
  37. Verma . H. . Garg . R. . Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis . Journal of Human Nutrition and Dietetics . Wiley . 30 . 5 . 2 February 2017 . 0952-3871 . 10.1111/jhn.12454 . 621–633. 28150351 . 19778171 .
  38. Fang . Xuexian . Wang . Kai . Han . Dan . He . Xuyan . Wei . Jiayu . Zhao . Lu . Imam . Mustapha Umar . Ping . Zhiguang . Li . Yusheng . Xu . Yuming . Min . Junxia . Wang . Fudi . Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies . BMC Medicine. 14 . 1 . 2016 . 210 . 1741-7015 . 10.1186/s12916-016-0742-z. 27927203 . 5143460 . free.
  39. Touyz . Rhian M. . de Baaij . Jeroen H.F. . Hoenderop . Joost G.J. . Magnesium Disorders . New England Journal of Medicine . 6 June 2024 . 390 . 21 . 1998–2009 . 10.1056/NEJMra1510603. 38838313 .
  40. Jahnen-Dechent . W. . Ketteler . M. . Magnesium basics . Clinical Kidney Journal . 1 February 2012 . 5 . Suppl 1 . i3–i14 . 10.1093/ndtplus/sfr163. 26069819 .
  41. Encyclopedia: Hypomagnesemia. Medterms medical dictionary a-z list. MedicineNet. Charles Patrick. Davis. 29 March 2021. 31 May 2014. 31 May 2014. https://web.archive.org/web/20140531090431/http://www.medterms.com/script/main/art.asp?articlekey=3858. dead.
  42. Swaminathan R . Magnesium metabolism and its disorders . The Clinical Biochemist. Reviews . 24 . 2 . 47–66 . May 2003 . 18568054 . 1855626 .
  43. Famularo G, Gasbarrone L, Minisola G . Hypomagnesemia and proton-pump inhibitors . Expert Opinion on Drug Safety . 12 . 5 . 709–716 . September 2013 . 23808631 . 10.1517/14740338.2013.809062 . 2726503 .
  44. Durlach J, Durlach V, Bac P, Bara M, Guiet-Bara A . Magnesium and therapeutics . Magnesium Research . 7 . 3–4 . 313–328 . December 1994 . 7786695 .
  45. Firoz M, Graber M . Bioavailability of US commercial magnesium preparations . Magnesium Research . 14 . 4 . 257–262 . December 2001 . 11794633 .
  46. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY . Magnesium bioavailability from magnesium citrate and magnesium oxide . Journal of the American College of Nutrition . 9 . 1 . 48–55 . February 1990 . 2407766 . 10.1080/07315724.1990.10720349 .
  47. Walker AF, Marakis G, Christie S, Byng M . Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study . Magnesium Research . 16 . 3 . 183–191 . September 2003 . 14596323 .
  48. Web site: United States Department of Agriculture . Abridged List Ordered by Nutrient Content in Household Measure Source: USDA National Nutrient Database for Standard Reference Legacy (2018) Nutrients: Magnesium, Mg(mg) . May 20, 2020.
  49. Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A . Hypomagnesemia and mortality in patients admitted to intensive care unit: a systematic review and meta-analysis . QJM . 109 . 7 . 453–459 . July 2016 . 27016536 . 10.1093/qjmed/hcw048 .
  50. Peres . Igor Tona . Hamacher . Silvio . Oliveira . Fernando Luiz Cyrino . Thomé . Antônio Márcio Tavares . Bozza . Fernando Augusto . What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis . Journal of Critical Care . December 2020 . 60 . 183–194 . 10.1016/j.jcrc.2020.08.003. 32841815 .
  51. Ye . Liu . Zhang . Cheng . Duan . Qin . Shao . Yue . Zhou . Jianzhong . Association of Magnesium Depletion Score With Cardiovascular Disease and Its Association With Longitudinal Mortality in Patients With Cardiovascular Disease . Journal of the American Heart Association . 19 September 2023 . 12 . 18 . e030077 . 10.1161/JAHA.123.030077. 37681518 . 10547298 .
  52. Hirschfelder AD, Haury VG . Clinical Manifestations of High and Low Plasma Magnesium; Dangers of Epsom Salt Purgation in Nephritis. Journal of the American Medical Association. 1934. 102. 14. 1138. 10.1001/jama.1934.02750140024010 .
  53. Book: Huner NP, Hopkins W . Introduction to Plant Physiology 4th Edition. John Wiley & Sons, Inc.. 978-0-470-24766-2. 3 & 4. 2008-11-07.
  54. Ding Y, Chang C, Luo W . High Potassium Aggravates the Oxidative Stress Induced by Magnesium Deficiency in Rice Leaves. Pedosphere. 2008 . 18. 3. 316–327 . 10.1016/S1002-0160(08)60021-1.
  55. Book: Merhaut DJ . Barker AV, Pilbeam DJ . Handbook of plant nutrition. 2006. CRC Press. Boca Raton. 9780824759049. 154. Merhaut 2006. Magnesium.
  56. Hermans C, Vuylsteke F, Coppens F . Systems Analysis of the responses to long-term magnesium deficiency and restoration in Arabidopsis thaliana . New Phytologist. 2010 . 187. 1 . 132–144 . 20412444 . 10.1111/j.1469-8137.2010.03257.x . 2066/83962 . free .
  57. Problem Solving: Magnesium Deficiency . Gardeners' World Magazine . 6 March 2019 .